XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Employee Benefit Plans (Tables)
9 Months Ended
Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award  
Transactions under the Company's stock option plans

    

    

    

Weighted

    

Weighted 

average

average 

remaining

Aggregate

exercise

contractual 

intrinsic

Shares

price

life in years

value

Outstanding at December 31, 2022

 

559,499

$

18.09

 

5.9

$

5,168,740

Options granted

 

 

 

 

 

 

Options exercised

 

(73,184)

 

 

19.04

 

 

 

 

Options forfeited

 

(1,332)

 

18.64

 

 

 

 

Options expired

 

 

 

 

 

 

Outstanding at September 30, 2023

 

484,983

$

17.95

 

5.2

$

2,659,163

Exercisable at September 30, 2023

445,825

$

17.85

 

5.0

$

2,488,426

Schedule of Information About Options Exercised

For the three months ended September 30, 

For the nine months ended September 30, 

    

2023

    

2022

    

2023

    

2022

Number of options exercised

 

22,249

23,168

 

73,184

 

 

85,877

Total intrinsic value of options exercised

$

164,978

215,476

480,981

 

$

1,081,833

Cash received from options exercised

$

394,665

441,272

 

1,393,551

 

 

1,394,809

Tax deduction realized from options

$

49,634

64,826

 

144,703

 

 

325,469

Schedule of Stock Options, by Exercise Price Range

Options outstanding

Options exercisable

    

Weighted average 

    

Weighted 

    

    

Weighted

Options

remaining contractual 

average 

Options

average

Range of exercise prices

outstanding

life (in years)

exercise price

exercisable

exercise price

$7.25 - 16.51

 

128,873

 

3.4

$

12.01

 

128,873

$

12.01

16.52 - 19.26

 

120,499

 

6.0

 

18.03

 

97,674

 

18.04

19.27 - 20.88

127,411

5.9

20.33

111,078

20.30

20.89 - 22.57

 

108,200

 

5.8

 

22.11

 

108,200

 

22.11

Total

 

484,983

 

5.2

$

17.95

 

445,825

$

17.85

Schedule of Nonvested Share Activity

    

    

Average grant

Shares

date fair value

Nonvested restricted stock at December 31, 2022

 

164,570

$

24.77

Granted

 

58,500

22.93

Cancelled

 

(4,599)

26.37

Vested

 

(41,973)

23.13

Nonvested restricted stock at September 30, 2023

 

176,498

$

24.51

Restricted Stock Grants

For the three months ended September 30, 

For the nine months ended September 30, 

    

2023

    

2022

2023

    

2022

Number of shares granted

 

3,000

 

2,000

58,500

 

73,000

Average grant date fair value

$

25.24

$

27.89

$

22.93

$

27.54

Stock Options  
Share-based Compensation Arrangement by Share-based Payment Award  
Allocation of Share-based Compensation Costs

For the three months ended September 30, 

For the nine months ended September 30, 

(In thousands)

    

2023

    

2022

2023

    

2022

Compensation expense

$

72

$

129

$

236

$

431

Income tax benefit

$

21

$

37

$

68

$

125

Restricted Stock  
Share-based Compensation Arrangement by Share-based Payment Award  
Allocation of Share-based Compensation Costs

For the three months ended September 30, 

For the nine months ended September 30, 

(In thousands)

    

2023

    

2022

2023

    

2022

Compensation expense

$

357

$

276

$

1,033

$

808

Income tax benefit

$

103

$

80

$

298

$

234